What is evidence?
- PMID: 20683888
- PMCID: PMC2917254
- DOI: 10.1002/sim.3933
What is evidence?
Abstract
The assumption that comparative effectiveness research will provide timely, relevant evidence rests on changing the current framework for assembling evidence. In this commentary, we provide the background of how coverage decisions for new medical technologies are currently made in the United States. We focus on the statistical issues regarding how to use the ensemble of information for inferring comparative effectiveness. It is clear a paradigm shift in how clinical information is integrated in real-world settings to establish effectiveness is required.
Copyright (c) 2010 John Wiley & Sons, Ltd.
Comment on
-
Comparative effectiveness research: Policy context, methods development and research infrastructure.Stat Med. 2010 Aug 30;29(19):1963-76. doi: 10.1002/sim.3818. Stat Med. 2010. PMID: 20564311
References
-
- [January 8, 2010]. See http://www.cms.hhs.gov/FACA/02_MEDCAC.asp.
-
- [January 8, 2010]. See http://www.cms.hhs.gov/FACA/Downloads.recommendations.pdf.
-
- Greenlander S, O’Rourke K. On the bias produced by quality scores in meta-analysis, and a hierarchical view of proposed solutions. Biostatistics. 2001;2(4):463–471. - PubMed
-
- Juni P, Witschi A, Block R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. Journal of the American Medical Association. 1999;282:1054–1060. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources